Biotech Values

[apljack]

Alexza's AZ-004 (Staccato® Loxapine)

I'd be cautious about taking a position based on this P3 trial result. I don't know too much about this co. but it fits our "unpartnered" category. More importantly, the drug being touted here doesn't have much of a market. The problem of mania-related bipolar agitation is a minor one, and it is a complication that is handled with relative ease using well established drugs already on the market. I have doubts that psychiatrists and/or ER physicians would use this largely unkown drug with no clinical track record.

aj